ASSET PORTFOLIO
A portfolio of signature-supported assets.
Sarborg owns a portfolio of technology, solid-form, and cocrystal patents - assets we acquired or identified, with our signature intelligence platform helping us evaluate, validate, and advance them.
01 / 02
Technology Patents
Core agentic platforms that decode signatures across biological and chemical domains.
T.01
Signature Agent
Patent No.
63/981,801
T.02
PRISM Agrichemical Agent
Patent No.
64/022,276
02 / 02
Pharmaceutical Patents
Solid-form and cocrystal assets we acquired or identified, with our signature engine supporting evaluation and development.
SRBG001
THCA
Patent No.
17/999,315
SRBG002
CBDA
Patent No.
12,319,649
SRBG003
CBG
Patent No.
17/640,822
SRBG004
CBDA Choline
Patent No.
63/919,886
SRBG005
Cystic Fibrosis Asset 1
Patent No.
64/058,811
SRBG006
Cystic Fibrosis Asset 2
Patent No.
64/058,811
Interested in our portfolio?
We partner on licensing, co-development, and acquisition across our patent portfolio.
Get in touch →